Tumor immune dysfunction and exclusion evaluation and chemoimmunotherapy response prediction in lung adenocarcinoma using pathomic-based approach

Tumor immune dysfunction and exclusion evaluation and chemoimmunotherapy response prediction in lung adenocarcinoma using pathomic-based approach

Saved in:

Bibliographic Details
Main Authors:	Wei Nie, Liang Zheng, Yinchen Shen, Yao Zhang, Haohua Teng, Runbo Zhong, Lei Cheng, Guangyu Tao, Baohui Han, Tianqing Chu, Hua Zhong, Xueyan Zhang, Xiangxiang Pan
Format:	Article
Language:	English
Published:	Wolters Kluwer 2025-02-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000003376
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The prognosis and metabolite changes of NSCLC patients receiving first‐line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification
by: Liang Zheng, et al.
Published: (2024-09-01)

Perioperative or neo/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
by: Qiong Zhang, et al.
Published: (2025-01-01)

Cis‐Regulation of an m6A Eraser by an Insertion Variant Associated with Survival of Patients With Non‐Small Cell Lung Carcinoma
by: Lei Cheng, et al.
Published: (2025-02-01)

Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
by: Yugo Matsumura, et al.
Published: (2025-01-01)

Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer
by: Jing Wang, et al.
Published: (2024-05-01)

Tiptoeing on Metastatic Adenocarcinoma of the Lung
by: Arupreet Kochar, et al.
Published: (2019-01-01)

Role of silent mutations in KRAS-mutant tumors
by: Jun Lu, et al.
Published: (2025-02-01)

Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01)

A Disentangled Representation-Based Multimodal Fusion Framework Integrating Pathomics and Radiomics for KRAS Mutation Detection in Colorectal Cancer
by: Zhilong Lv, et al.
Published: (2024-09-01)

Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
by: Xiayi Zhu, et al.
Published: (2025-02-01)

Thapsigargin Induces Apoptosis by Impairing Cytoskeleton Dynamics in Human Lung Adenocarcinoma Cells
by: Fei Wang, et al.
Published: (2014-01-01)

Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study
by: Yutong Wu, et al.
Published: (2024-09-01)

Advancing precision medicine: the transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization
by: Luchen Chang, et al.
Published: (2025-01-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Metagenomic and Transcriptomic Analysis Reveals Crosstalk Between Intratumor Mycobiome and Hosts in Early‐Stage Nonsmoking Lung Adenocarcinoma Patients
by: Yaohui Sun, et al.
Published: (2025-01-01)

Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report
by: Jialin Qian, et al.
Published: (2025-03-01)

Development of metastasis and survival prediction model of luminal and non-luminal breast cancer with weakly supervised learning based on pathomics
by: Hui Liu, et al.
Published: (2025-01-01)

Pancreatic metastasis from lung adenocarcinoma
by: Naoki Aoyama, et al.
Published: (2023-05-01)

Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China
by: Hua Zhong, et al.
Published: (2024-12-01)

Exploring the mechanism of rosmarinic acid in the treatment of lung adenocarcinoma based on bioinformatics methods and experimental validation
by: Chaowang Zhou, et al.
Published: (2025-01-01)

Intestinal Type of Lung Adenocarcinoma in Younger Adults
by: Jelena Stojsic, et al.
Published: (2014-01-01)

Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma
by: Ruilan Ma, et al.
Published: (2025-02-01)

Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma
by: Yue-Hua Zhang, et al.
Published: (2018-01-01)

Determination and evaluation of serum monosaccharides in patients with early-stage lung adenocarcinoma
by: Wenhao Su, et al.
Published: (2025-02-01)

Exclusion Spirometry: An Initiative to Increase Lung Function Assessment in Primary Care
by: José Almirall, et al.
Published: (2004-01-01)

Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma
by: Juan Li, et al.
Published: (2022-01-01)

A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma
by: Fan Yang, et al.
Published: (2022-01-01)

Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
by: Huiping Qiang, et al.
Published: (2025-03-01)

Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma
by: Hui Tang, et al.
Published: (2022-01-01)

EGFR-Mutant Lung Adenocarcinoma Mimicking a Pneumonia
by: Álvaro Taus, et al.
Published: (2012-01-01)

Screening and validation of tsRNAs associated with lung adenocarcinoma
by: LU Chunli, et al.
Published: (2025-01-01)

Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy
by: Shuai Wang, et al.
Published: (2025-02-01)

TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01)

Clinical characteristics and outcomes of surgical resection for brain metastases from lung adenocarcinoma
by: Ming Li, et al.
Published: (2025-01-01)

Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
by: Fang Ye, et al.
Published: (2024-04-01)

Paraneoplastic Mononeuritis Multiplex as a Presenting Feature of Adenocarcinoma of the Lung
by: Esra Ekiz, et al.
Published: (2013-01-01)

A case of leptomeningeal metastasis originating from lung adenocarcinoma
by: Jiadong Song, et al.
Published: (2025-02-01)

Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma
by: Ji’an Zou, et al.
Published: (2025-01-01)

A preoperative predictive model based on multi-modal features to predict pathological complete response after neoadjuvant chemoimmunotherapy in esophageal cancer patients
by: Yana Qi, et al.
Published: (2025-01-01)

EXO1 is a key gene for lung-resident memory T cells and has diagnostic and predictive values for lung adenocarcinoma
by: Zhuoqi Li, et al.
Published: (2025-02-01)